Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003103796 | SCV000601193 | likely benign | not provided | 2023-06-13 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003103796 | SCV000603866 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834633 | SCV002093864 | uncertain significance | alpha Thalassemia | 2017-08-09 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003979906 | SCV004787992 | likely benign | HBA1-related disorder | 2024-07-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |